Stay updated on Efficacy Safety Tislelizumab Fruquintinib Combo Clinical Trial
Sign up to get notified when there's something new on the Efficacy Safety Tislelizumab Fruquintinib Combo Clinical Trial page.

Latest updates to the Efficacy Safety Tislelizumab Fruquintinib Combo Clinical Trial page
- CheckyesterdayChange DetectedThe page shows a new minor version revision tag (v3.6.2) replacing the previous v3.6.0. This indicates a platform update that does not affect the study data or its presentation.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedNew recruitment status and help/navigation sections were added, including 'No longer looking for participants' and 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study'. The page also updates the labeling of 'Intervention/Treatment' and updates the revision note to 'Revision: v3.6.0' (replacing v3.5.5).SummaryDifference0.4%

- Check23 days agoChange DetectedThe page now displays Revision: v3.5.5, replacing the previous v3.5.4, indicating a small update to the page's underlying document/template.SummaryDifference0.0%

- Check44 days agoChange DetectedThe page revision label has been updated from v3.5.3 to v3.5.4, indicating a newer version of the page. This update does not modify the study details or surrounding content.SummaryDifference0.0%

- Check59 days agoChange DetectedThe page revision was updated from v3.5.2 to v3.5.3, indicating an internal update to the site's infrastructure. It does not change the study details, eligibility criteria, or outcomes.SummaryDifference0.0%

- Check73 days agoChange DetectedFooter revision label updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

Stay in the know with updates to Efficacy Safety Tislelizumab Fruquintinib Combo Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy Safety Tislelizumab Fruquintinib Combo Clinical Trial page.